Filter
504
Filtered Results: 504
Text search:
in
vitro
diagnostic
tests
Featured
Recommendations
68
New Publications
105
Language
Document type
No document type
232
Guidelines
130
Studies & Reports
60
Manuals
45
Strategic & Response Plan
14
Fact sheets
14
Training Material
5
Situation Updates
2
Resource Platforms
2
Countries / Regions
India
26
Germany
15
Global
12
Latin America and the Carribbean
12
South Africa
11
Africa
10
Western and Central Europe
10
Kenya
7
Russia
7
Tanzania
6
Rwanda
5
Brazil
5
Ethiopia
5
Cameroon
4
Nigeria
4
Eastern Europe
4
Namibia
4
Nepal
3
Senegal
3
Congo-Brazzaville
3
Burkina Faso
3
Malawi
3
West and Central Africa
3
Uganda
3
Zambia
3
Ukraine
2
Benin
2
Sierra Leone
2
Togo
2
Niger
2
Haiti
2
Asia
2
Venezuela
2
Congo, Democratic Republic of
2
Middle East and North Africa
2
France
2
East and Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Bangladesh
2
Mali
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Colombia
1
Turkey
1
Gambia
1
Chile
1
Syria
1
Albania
1
Canada
1
Laos
1
Burundi
1
Peru
1
Zimbabwe
1
Philippines
1
Guinea
1
USA
1
South–East Asia Region
1
Luxembourg
1
North America
1
Belgium
1
Southern Africa
1
Bolivia
1
Djibouti
1
Yemen
1
Angola
1
South Sudan
1
Indonesia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
118
Clinical Guidelines
109
Pharmacy & Technologies
40
Public Health
16
Women & Child Health
16
Key Resources
10
Toolboxes
TB
71
COVID-19
69
HIV
65
AMR
32
NTDs
29
Rapid Response
21
Pharmacy
16
Refugee
12
Ebola
12
Zika
12
Mental Health
8
Caregiver
8
Polio
6
Planetary Health
4
Cholera
2
Global Health Education
2
Specific Hazards
1
Natural Hazards
1
NCDs
1
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Cancer centres are a major resource in ensuring a comprehensive approach to cancer treatment and its planning. As part of a new roadmap developed by WHO and IAEA to help countries design national cancer control programmes, this publication proposes a framework to develop a cancer centre and/or to st...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
To support countries in adapting their response to different COVID-19 scenarios, the World Health
Organization (WHO) Department of Maternal, Newborn, Child and Adolescent Health and Ageing commissioned this scoping review of published and grey literature. The objective was to identify interventions...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
At the forefront of DNDi’s efforts to develop new treatments is the need to understand the realities and treatment needs of patients and health care staff in the field. The ultimate goal for human African trypanosomiasis (HAT) is a truly simplified
treatment which can be orally administered, impl...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Tuberculosis. Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child...
The country profiles incorporate facts indicating the national status of medical devices in areas such as: medical device policies, regulations, incorporation, lists, inventories, nomenclature, health technology assessment, management, and biomedical engineering resources. This publication is int...
The objective of this project was to list the medical devices required to provide the essential reproductive, maternal, newborn and child health interventions defined by existing WHO guidelines and publications, in order to improve access to these devices in low- and middle-income countries, support...
This guidance addresses rationale, risk-based scenarios, practical considerations prior to adoption of the self-testing products, quality assurance, safety and ethical considerations, and data management considerations for COVID-19 self-testing. The Africa CDC recommends the use of rapid antigen sel...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
On 17 October 2017, the Ugandan Ministry of Health notified WHO of a confirmed Marburg outbreak of Marburg Virus disease (MVD) in Kween district, Eastern Uganda. The outbreak was officially declared by the Ministry of health on 19 October 2017.
As of 7 November, four cases of MVD have been reported...
The provision of safe and efficacious blood and blood components for transfusion or manufacturing use involves a number of processes, from the selection of blood donors and the collection, processing and testing of blood donations to the testing of patient samples, the issue of compatible blood and ...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
The strategy focuses on mobilizing and coordinating partners, experts and resources to help countries enhance surveillance of the Zika virus and disorders that could be linked to it, improve vector control, effectively communicate risks, guidance and protection measures, provide medical care to thos...
This report outlines the Ministry of Health’s National Health Research Agenda in which it identifies research priorities in health. It will be implemented in the same time frame as the Health Sector Strategic Plain 2012-2018. The Ministry of Health being the implementing agency of this document, i...
